标题
PPARs as Nuclear Receptors for Nutrient and Energy Metabolism
作者
关键词
-
出版物
MOLECULES
Volume 24, Issue 14, Pages 2545
出版商
MDPI AG
发表日期
2019-07-12
DOI
10.3390/molecules24142545
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Interactions between Host PPARs and Gut Microbiota in Health and Disease
- (2019) Arif Hasan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment
- (2019) Koutaro Yokote et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular actions of PPARα in lipid metabolism and inflammation
- (2018) Nadia Bougarne et al. ENDOCRINE REVIEWS
- The Role of PPAR and Its Cross-Talk with CAR and LXR in Obesity and Atherosclerosis
- (2018) Pengfei Xu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The antagonistic effect of selenium on cadmium-induced apoptosis via PPAR-γ/PI3K/Akt pathway in chicken pancreas
- (2018) Xi Jin et al. JOURNAL OF HAZARDOUS MATERIALS
- Insights into the role of hepatocyte PPARα activity in response to fasting
- (2018) Marion Régnier et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development
- (2018) Fan Hong et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PPARs and Metabolic Disorders Associated with Challenged Adipose Tissue Plasticity
- (2018) Patricia Corrales et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Role of PPAR-δ in Metabolism, Inflammation, and Cancer: Many Characters of a Critical Transcription Factor
- (2018) Yi Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue
- (2018) Daniel Heudobler et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pioglitazone improves visceral sensation and colonic permeability in a rat model of irritable bowel syndrome
- (2018) Tsukasa Nozu et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Nuciferine Inhibits Proinflammatory Cytokines via the PPARs in LPS-Induced RAW264.7 Cells
- (2018) Chao Zhang et al. MOLECULES
- Fasting Imparts a Switch to Alternative Daily Pathways in Liver and Muscle
- (2018) Kenichiro Kinouchi et al. Cell Reports
- PPARγ activation ameliorates postoperative cognitive decline probably through suppressing hippocampal neuroinflammation in aged mice
- (2017) Zhijie Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The role of various peroxisome proliferator-activated receptors and their ligands in clinical practice
- (2017) Giuseppe Derosa et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Nutrient-sensing nuclear receptors PPARα and FXR control liver energy balance
- (2017) Geoffrey A. Preidis et al. JOURNAL OF CLINICAL INVESTIGATION
- Distinct but complementary contributions of PPAR isotypes to energy homeostasis
- (2017) Vanessa Dubois et al. JOURNAL OF CLINICAL INVESTIGATION
- Pioglitazone Attenuates Neuroinflammation and Promotes Dopaminergic Neuronal Survival in the Nigrostriatal System of Rats after Diffuse Brain Injury
- (2017) Mei Liu et al. JOURNAL OF NEUROTRAUMA
- Melatonin prevents obesity through modulation of gut microbiota in mice
- (2017) Pengfei Xu et al. JOURNAL OF PINEAL RESEARCH
- Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
- (2017) Hao Wu et al. NATURE MEDICINE
- ADAMTS1-mediated targeting of TSP-1 by PPARδ suppresses migration and invasion of breast cancer cells
- (2017) Sun Ah Ham et al. Oncotarget
- DBZ (Danshensu Bingpian Zhi), a Novel Natural Compound Derivative, Attenuates Atherosclerosis in Apolipoprotein E–Deficient Mice
- (2017) Jing Wang et al. Journal of the American Heart Association
- Dual Outcomes of Rosiglitazone Treatment on Fatty Liver
- (2016) Mingming Gao et al. AAPS Journal
- Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis
- (2016) Nadira Ruzehaji et al. ANNALS OF THE RHEUMATIC DISEASES
- The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis
- (2016) Nathalie Hennuyer et al. ATHEROSCLEROSIS
- Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial
- (2016) Shun Ishibashi et al. ATHEROSCLEROSIS
- Leucine stimulates PPARβ/δ-dependent mitochondrial biogenesis and oxidative metabolism with enhanced GLUT4 content and glucose uptake in myotubes
- (2016) Jamie K. Schnuck et al. BIOCHIMIE
- Targeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics
- (2016) William James Deardorff et al. Expert Review of Neurotherapeutics
- Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
- (2016) Alexandra Montagner et al. GUT
- T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer’s Disease
- (2016) Ming Tong et al. JOURNAL OF ALZHEIMERS DISEASE
- High-fat diet enhances stemness and tumorigenicity of intestinal progenitors
- (2016) Semir Beyaz et al. NATURE
- PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
- (2016) Barbara Gross et al. Nature Reviews Endocrinology
- High-fat diet modifies the PPAR-γ pathway leading to disruption of microbial and physiological ecosystem in murine small intestine
- (2016) Julie Tomas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Unraveling the Effects of PPARβ/δ on Insulin Resistance and Cardiovascular Disease
- (2016) Manuel Vázquez-Carrera TRENDS IN ENDOCRINOLOGY AND METABOLISM
- A Mathematical Model of the Liver Circadian Clock Linking Feeding and Fasting Cycles to Clock Function
- (2016) Aurore Woller et al. Cell Reports
- Targeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics
- (2016) William James Deardorff et al. Expert Review of Neurotherapeutics
- PPAR-delta promotes survival of breast cancer cells in harsh metabolic conditions
- (2016) X Wang et al. Oncogenesis
- Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders
- (2016) Sung Sik Choe et al. Frontiers in Endocrinology
- Hepatic circadian clock oscillators and nuclear receptors integrate microbiome-derived signals
- (2016) Alexandra Montagner et al. Scientific Reports
- PPARs and ERRs: molecular mediators of mitochondrial metabolism
- (2015) Weiwei Fan et al. CURRENT OPINION IN CELL BIOLOGY
- Saroglitazar for the treatment of dyslipidemia in diabetic patients
- (2015) Shashank R Joshi EXPERT OPINION ON PHARMACOTHERAPY
- Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice
- (2015) Rebecca Skerrett et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
- (2015) Michal Pawlak et al. JOURNAL OF HEPATOLOGY
- Fenofibrate (PPARalpha agonist) induces beige cell formation in subcutaneous white adipose tissue from diet-induced male obese mice
- (2015) Tamiris Lima Rachid et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Pioglitazone may impair L-DOPA anti-parkinsonian efficacy in the MPTP-lesioned macaque: Results of a pilot study
- (2015) Philippe Huot et al. SYNAPSE
- Peroxisome proliferator-activated receptorβ/δ activation is essential for modulating p-Foxo1/Foxo1 status in functional insulin-positive cell differentiation
- (2015) L Li et al. Cell Death & Disease
- Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment
- (2015) Xiaohua Li et al. Clinical Interventions in Aging
- Human Muscle Fiber Type–Specific Insulin Signaling: Impact of Obesity and Type 2 Diabetes
- (2014) Peter H. Albers et al. DIABETES
- Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis
- (2014) Daniel Levin et al. DIABETOLOGIA
- Maternal High-Fat Diet Modulates Hepatic Glucose, Lipid Homeostasis and Gene Expression in the PPAR Pathway in the Early Life of Offspring
- (2014) Jia Zheng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PPARδ activation attenuates hepatic steatosis inLdlr−/−mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity
- (2014) Lazar A. Bojic et al. JOURNAL OF LIPID RESEARCH
- An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ
- (2014) Alexander S. Banks et al. NATURE
- PPARγ and the global map of adipogenesis and beyond
- (2014) Martina I. Lefterova et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Selective peroxisome proliferator-activated receptorα modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
- (2013) Jean-Charles Fruchart Cardiovascular Diabetology
- Reprogramming of the Circadian Clock by Nutritional Challenge
- (2013) Kristin L. Eckel-Mahan et al. CELL
- Dual Peroxisome Proliferator-Activated Receptor / Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects
- (2013) B. Cariou et al. DIABETES CARE
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- PPARγ signaling and metabolism: the good, the bad and the future
- (2013) Maryam Ahmadian et al. NATURE MEDICINE
- Possible Role of Intestinal Fatty Acid Oxidation in the Eating-Inhibitory Effect of the PPAR-α Agonist Wy-14643 in High-Fat Diet Fed Rats
- (2013) Elnaz Karimian Azari et al. PLoS One
- Lipid Effects of Peroxisome Proliferator-Activated Receptor-Δ Agonist GW501516 in Subjects With Low High-Density Lipoprotein Cholesterol
- (2012) Eric J. Olson et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Pparγ
- (2012) Li Qiang et al. CELL
- Time-Restricted Feeding without Reducing Caloric Intake Prevents Metabolic Diseases in Mice Fed a High-Fat Diet
- (2012) Megumi Hatori et al. Cell Metabolism
- Thiazolidinediones and PPARγ agonists: time for a reassessment
- (2012) Bertrand Cariou et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- In VitroandIn VivoCharacterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist
- (2012) B. K. He et al. PPAR Research
- Revisiting glitazars: Thiophene substituted oxazole containing α-ethoxy phenylpropanoic acid derivatives as highly potent PPARα/γ dual agonists devoid of adverse effects in rodents
- (2011) Preeti Raval et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Role of Lipid Peroxidation and PPAR-δ in Amplifying Glucose-Stimulated Insulin Secretion
- (2011) Guy Cohen et al. DIABETES
- Effects of the New Dual PPAR / Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients With Combined Dyslipidemia or Impaired Glucose Metabolism
- (2011) B. Cariou et al. DIABETES CARE
- The PPARβ/δ Activator GW501516 Prevents the Down-Regulation of AMPK Caused by a High-Fat Diet in Liver and Amplifies the PGC-1α-Lipin 1-PPARα Pathway Leading to Increased Fatty Acid Oxidation
- (2011) Emma Barroso et al. ENDOCRINOLOGY
- Inhibition of adipocyte differentiation and adipogenesis by the traditional Chinese herb Sibiraea angustata
- (2011) Lei Xiao et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts
- (2011) Eva Morán-Salvador et al. FASEB JOURNAL
- Diabetes: New conductors for the peroxisome proliferator-activated receptor γ (PPARγ) orchestra
- (2011) Jonathan P. Whitehead INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin
- (2011) Harold E. Bays et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes
- (2011) Tsuyoshi Goto et al. JOURNAL OF LIPID RESEARCH
- Fasting Induces the Expression of PGC-1α and ERR Isoforms in the Outer Stripe of the Outer Medulla (OSOM) of the Mouse Kidney
- (2011) Christina T. Teng et al. PLoS One
- PPARs: diverse regulators in energy metabolism and metabolic diseases
- (2010) Yong-Xu Wang CELL RESEARCH
- PPARα contributes to colonic protection in mice with DSS-induced colitis
- (2010) Yasu-Taka Azuma et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Role of Peroxisome Proliferator-activated Receptor δ/β in Hepatic Metabolic Regulation
- (2010) Sihao Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Endogenous Ligands for Nuclear Receptors: Digging Deeper
- (2010) Michael Schupp et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
- (2010) Jang Hyun Choi et al. NATURE
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Role of PPAR in Hepatic Carbohydrate Metabolism
- (2010) Annelies Peeters et al. PPAR Research
- The effect of PPAR-α agonism on apolipoprotein metabolism in humans
- (2009) Ashish Shah et al. ATHEROSCLEROSIS
- Activation of PPARδ up-regulates fatty acid oxidation and energy uncoupling genes of mitochondria and reduces palmitate-induced apoptosis in pancreatic β-cells
- (2009) Jun Wan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux
- (2009) Carlos L. J. Vrins et al. JOURNAL OF LIPID RESEARCH
- PIOGLITAZONE IMPROVED COGNITION IN A PILOT STUDY ON PATIENTS WITH ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT WITH DIABETES MELLITUS
- (2009) Haruo Hanyu et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Regulation of peroxisome proliferator-activated receptor-β/δ by the APC/β-CATENIN pathway and nonsteroidal antiinflammatory drugs
- (2009) Jennifer E. Foreman et al. MOLECULAR CARCINOGENESIS
- Transcriptional profiling reveals divergent roles of PPARα and PPARβ/δ in regulation of gene expression in mouse liver
- (2009) Linda M. Sanderson et al. PHYSIOLOGICAL GENOMICS
- Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
- (2008) R. Scott et al. DIABETES CARE
- Effect of fasting on PPARγ and AMPK activity in adipocytes
- (2008) Kazuo Kajita et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Peroxisome proliferator-activated receptor-δ induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice
- (2008) Xiaomei Qin et al. HEPATOLOGY
- Integration of metabolism and inflammation by lipid-activated nuclear receptors
- (2008) Steven J. Bensinger et al. NATURE
- Hepatic Fatty Acid Transporter Cd36 Is a Common Target of LXR, PXR, and PPARγ in Promoting Steatosis
- (2007) Jie Zhou et al. GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started